US Patent 9540351 Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
Patent 9540351 was granted and assigned to Axikin Pharmaceuticals on January, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9540351 Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.